Organisation Clinique Diagnostic Research Formation
Home  <  Research  <  Publications Plan d'accèsPlan du siteImprimer
  Search
  
Archives 2002-2007
Service d'immunologie et d'allergie
CHUV BH19-650
Rue du Bugnon 46
1011 Lausanne
Répondants du site: ial.info@chuv.ch
www.chuv.ch

2008   |  2009   |  2010


Publications : 2010 Debut de page
1: Aubert C., Vaudaux B. and Bart P.-A.
    Immunization guidelines regarding patients with a chronic disease.
Rev. Med. Suisse 2010, 6:798-803.
2: Cellerai C., Perreau M., Rozot V., Enders F.B., Pantaleo G. and Harari A.
    Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression.
J. Virol. 2010, 84:3868-3878.
3: Chappuis S., Vogt P., Petitpierre S., Leimgruber A., Spertini F. and Bart P.-A.
    Cardiac involvement in connective tissue disease: the example of systemic lupus erythematosus.
Rev. Med. Suisse 2010, 6:804, 806-811.
4: Ciuffreda D., Codarri L., Buhler L., Vallotton L., Giostra E., Mentha G., Morel P., Pantaleo G. and Pascual M.
    Hepatitis C virus infection after liver transplantation is associated with lower levels of activated CD4(+)CD25(+)CD45RO(+)IL-7ralpha(high) T cells.
Liver Transpl. 2010, 16:49-55.
5: Corthésy B.
    Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces.
Future Microbiol. 2010, 5:817-829.
6: Cvetkovic-Lopes V., Bayer L., Dorsaz S., Maret S., Pradervand S., Dauvilliers Y., Lecendreux M., Lammers G.J., Donjacour C.E., Du Pasquier R.A., Pfister C., Petit B., Hor H., Mühlethaler M. and Tafti M.
    Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients.
J. Clin. Invest. 2010, 120:713-719.
7: Decrausaz L, Revaz V, Bobst M, Corthésy B, Romero P, Nardelli-Haefliger D.
    Induction of human papillomavirus oncogene-specific CD8 T-cell effector responses in the genital mucosa of vaccinated mice.
Int. J. Cancer 2010, 126:2469-2478.
8: Du Pasquier R.A.
    A promenade along the stream of demyelination.
Curr. Opin. Neurol. 2010., 23:203-204.
9: Duc M., Johansen F.E. and Corthésy B.
    Antigen binding to secretory immunoglobulin A results in decreased sensitivity to intestinal proteases and increased binding to cellular Fc receptors.
J. Biol. Chem. 2010, 285:953-960.
10: Duchez S., Amin R., Cogné N., Delpy L., Sirac C., Pascal V., Corthésy B. and Cogné M.
    Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation.
Proc. Natl. Acad. Sci. USA 2010, 107:3064-3069.
11: Elzi L., Marzolini C., Furrer H., Ledergerber B., Cavassini M., Hirschel B., Vernazza P., Bernasconi E., Weber R., Battegay M.; Swiss HIV Cohort Study.
    Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.
Arch. Intern. Med. 2010, 170:57-65.
12: Fontana M., Moradpour D., Aubert V., Pantaleo G. and Pascual M.
    Prevalence of anti-HLA antibodies after liver transplantation.
Transpl Int. 2010. In press.
13: Gambillara E., Spertini F. and Leimgruber A.
    Allergic and toxic cutaneous reactions to plants.
Rev. Med. Suisse 2010, 6:824-829.
14: Guglietta S., Pantaleo G. and Graziosi C.
    Long sequence duplications, repeats and palindromes in HIV-1 gp120: length variation in V4 as the product of misalignment mechanism.
Virology 2010, 399:178-186.
15: Jaquiéry E., Jilek S., Schluep M., Le Goff G., Garcia M., Pantaleo G. and Du Pasquier R.A.
    Cytokine mRNA profile of Epstein-Barr virus-stimulated highly differentiated T cells in multiple sclerosis: A pilot study.
J. Neuroimmunol. 2010. In press.
16: Jaquiéry E., Jilek S., Schluep M., Meylan P., Lysandropoulos A., Pantaleo G. and Du Pasquier R.A.
    Intrathecal immune responses to Epstein-Barr virus in early multiple sclerosis.
Eur. J. Immunol. 2010, 40:878-887.
17: Jilek S., Jaquiéry E., Hirsch H.H., Lysandropoulos A., Canales M., Guignard L., Schluep M., Pantaleo G. and Pasquier R.A.
    Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.
Lancet Neurol. 2010, 9:264-272.
18: Létourneau S., van Leeuwen E.M., Krieg C., Martin C., Pantaleo G., Sprent J., Surh C.D. and Boyman O.
    IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25.
Proc. Natl. Acad. Sci. USA 2010, 107:2171-2176.
19: Lysandropoulos A.P. and Du Pasquier R.A.
    Demyelination as a complication of new immunomodulatory treatments.
Curr. Opin. Neurol. 2010, 23:226-233.
20: Olugbile S., Habel C., Servis C., Spertini F., Verdini A. and Corradin G.
    Malaria vaccines - The long synthetic peptide approach: Technical and conceptual advancements.
Curr. Opin. Mol. Ther. 2010, 12:64-76.
21: Oviedo-Orta E., Perreau M., Evans W.H. and Potolicchio I.
    Control of the proliferation of activated CD4+ T cells by connexins.
J. Leukoc. Biol. 2010. In press.
22: Rey V., Du Pasquier R., Muehl A., Péter O. and Michel P.
    Multiple ischemic strokes due to Borrelia garinii meningovasculitis.
Rev. Neurol. (Paris) 2010. In press.
23: Seebach J., Bart P.-A. and Spertini F.
    In Process Citation.
Rev. Med. Suisse 2010, 6:795-796.
24: Simioni S., Cavassini M., Anonni J.-M., Rimbault-Abraham A., Bourquin I., Schiffer V., Calmy A., Chave J.-P., Giacobini E., Hirschel B. and Du Pasquier R.A.
    Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.
AIDS 2010. In press.
25: Spertini F., Berney M., Foradini F. and Roulet CA.
    Major mite allergen Der f 1 concentration is reduced in buildings with improved energy performance.
Allergy 2010, 65:623-629.

Publications : 2009 Debut de page
1: Aubert V., Venetz J.-P., Pantaleo G. and Pascual M.
    Are all donor-specific antibodies detected by solid-phase assay before transplantation clinically relevant ?
Transplantation 2009, 87:1897-1898.
2: Aubert V., Venetz J.-P., Pantaleo G. and Pascual M.
    Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Hum. Immunol. 2009, 70:580-583.
3: Audran R., Lurati-Ruiz F., Genton B., Blythman H.E., Ofori-Anyinam O., Reymond C., Corradin G. and Spertini F.
    The synthetic Plasmodium falciparum circumsporozoite peptide PfCS102 as a malaria vaccine candidate: a randomized controlled phase I trial.
PLoS One 2009, 4:e7304.
4: Bélair M., Dovat M., Foley B., Mayerat C., Pantaleo G. and Graziosi C.
    The polymorphic nature of HIV type 1 env V4 affects the patterns of potential N-glycosylation sites in proviral DNA at the intrahost level.
AIDS Res. Hum. Retroviruses 2009, 25:199-206.
5: Boudousquié C., Pellaton C., Barbier N. and Spertini F.
    CD4+CD25+ T cell depletion impairs tolerance induction in a murine model of asthma.
Clin. Exp. Allergy 2009, 39:1415-1426.
6: Boullier S., Tanguy M., Kadaoui K.A., Caubet C., Sansonetti P., Corthésy B. and Phalipon A.
    Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits.
J. Immunol. 2009, 183:5879-5885.
7: Boyman O., Létourneau S., Krieg C. and Sprent J.
    Homeostatic proliferation and survival of naïve and memory T cells.
Eur. J. Immunol. 2009, 39:2088-2094.
8: Bunbury A., Potolicchio I., Maitra R. and Santambrogio L.
    Functional analysis of monocyte MHC class II compartments.
FASEB J. 2009, 23:164-171.
9: Castillo J., Comegna M., Quijada W., Jauvin V., Pinson P., Masquelier B., Fleury H. and Castro E.
    Surveillance of HIV-1 drug resistance among naive patients from Venezuela.
AIDS Res. Hum. Retroviruses 2009, 25:1329-1333.
10: Cellerai C., Perreau M., Rozot V., Bellutti Enders F., Bart P.-A., Pantaleo G. and Harari A.
    Antigen exposure regulates the balance between proliferating and cytotoxic subsets of virus-specific CD8 T-cells
Retrovirology 2009, 6(Suppl 3):261.
11: Chakour R., Leimgruber A., Bart P.-A. and Spertini F.
    Therapeutic strategies in idiopatic inflammatory myopathies.
Rev. Med. Suisse 2009, 5:812-818.
12: Clerc O., Cavassini M., Böni J., Schüpbach J. and Bürgisser P.
    Prolonged seroconversion in an elite controller of HIV-1 infection.
J. Clin. Virol. 2009, 46:371-373.
13: Comte-Perret S., Bart P.-A., Spertini F. and Leimgruber A.
    Mastocytosis: when should it be considered ?
Rev. Med. Suisse 2009, 5:837-842.
14: Corthésy B.
    Secretory immunoglobulin A: well beyond immune exclusion at mucosal surfaces.
Immunopharmacol. Immunotoxicol. 2009, 31:174-179.
15: Delaloye J., Roger T., Steiner-Tardivel Q.G., Le Roy D., Knaup Reymond M., Akira S., Petrilli V., Gomez C.E., Perdiguero B., Tschopp J., Pantaleo G., Esteban M. and Calandra T.
    Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome.
PLoS Pathog. 2009, 5:e1000480.
16: Du Pasquier R., Cavassini M., Simioni S., Annoni J.M., Giacobini E. and Hirschel B.
    New spectrum of HIV-associated cognitive disorders in the HAART era.
Rev. Med. Suisse 2009, 5:955-956, 958-961.
17: Dunand M., Botez S.A., Borruat F.X., Roux-Lombard P., Spertini F. and Kuntzer T.
    Unsatisfactory outcomes in myasthenia gravis: influence by care providers.
J. Neurol. 2009. In press.
18: Harari A., Bellutti Enders F., Cellerai C., Bart P.-A. and Pantaleo G.
    Distinct profiles of cytotoxic granules in memory CD8 T-cells correlate with function, differentiation stage and antigen exposure.
J. Virol. 2009, 83:2862-2871.
19: Jaquiéry E. , Jilek S. , Schluep M. , Meylan P. , Lysandropoulos A. , Pantaleo G. and Du Pasquier R.A.
    Increased EBV reactivation in the cerebrospinal fluid of patients with early multiple sclerosis.
J. Neurovirol. 2009, 15:38.
20: Jilek Terrasse S. , Lysandropoulos A. , Jaquiéry E. , Canales M. , Guignard L. , Campiche C. , Schluep M. , Pantaleo G. and Du Pasquier R.A.
    Viral- and myelin-specific cellular immune response in patients treated with natalizumab: a cross-sectional and a longitudinal prospective study.
J. Neurovirol. 2009, 15 (Suppl. 1):39-40.
21: Khanna N., Wolbers M., Mueller N.J., Garzoni C., Du Pasquier R.A., Fux C.A., Vernazza P., Bernasconi E., Viscidi R., Battegay M. and Hirsch H.H.; Swiss HIV Cohort Study.
    JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.
J. Virol. 2009, 83:4404-4411.
22: Krieg C. and Boyman O.
    The role of chemokines in cancer immune surveillance by the adaptive immune system.
Semin. Cancer Biol. 2009, 19:76-83.
23: Létourneau S., Krieg C., Pantaleo G. and Boyman O.
    IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets.
J. Allergy Clin. Immunol. 2009, 123:758-762.
24: Lê Huu S., Spertini F., Roggero P., Egloff D.V. and Raffoul W.
    Pyoderma gangrenosum: a rare pathology or an omitted diagnosis ?
Ann. Chir. Plast. Esthet. 2009, 54:82-87.
25: Lalive P.H., Chofflon M., Du Pasquier R.A. and Burkhard P.R.
    Autoantibodies in neurological diseases: clinical implications
Rev. Med. Suisse 2009, 5:942-944, 946-948, 950.
26: Leimgruber A. and Spertini F.
    Allergie rhinoconjunctivitis and immunotherapy: an uptodate.
Rev. Med. Suisse 2009, 14:88-93.
27: Mooij P., Balla-Jhagjhoorsingh S.S., Beenhakker N., van Haaften P., Baak I., Nieuwenhuis I.G., Heidari S., Wolf H., Frachette M.J., Bieler K., Sheppard N., Harari A., Bart P.-A., Liljeström P., Wagner R., Pantaleo G. and Heeney JL.
    Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding HIV-1 clade C immunogens.
J. Virol. 2009, 83:5881-5889.
28: Novy J., Carota A., Eggiman D., Pusztaszeri M., Rossetti A.O. and Du Pasquier R.A.
    Encephalitis, HSV-2 in the cerebrospinal fluid and anti-RI (ANNA-2) antibodies: an infectious or a paraneoplastic syndrome ?
BMJ Case Reports. August 11, 2009.
29: Olugbile S., Kulangara C., Bang G., Bertholet S., Suzarte E., Villard V., Frank G., Audran R., Razaname A., Nebie I., Awobusuyi O., Spertini F., Kajava A.V., Felger I., Druilhe P. and Corradin G.
    Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165c.
Infect. Immun. 2009, 77:5701-5709.
30: Perrier C., Thierry A.C., Mercenier A. and Corthésy B.
    Allergen-specific antibody and cytokine responses, mast cell reactivity and intestinal permeability upon oral challenge of sensitized and tolerized mice.
Clin. Exp. Allergy 2009, 40:153-162.
31: Petitpierre S., Aubert V., Leimgruber A., Spertini F. and Bart P.-A.
    Use of autoantibodies in clinical practice.
Rev. Med. Suisse 2009, 5:823-831.
32: Rosselet A., Vu D.H., Meylan P., Chaubert A.S., Schapira M., Pascual M., Aubert V., Tissot J.D. and Duchosal M.A.
    Associations of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease.
Clin. Transplant. 2009, 23:74-82.
33: Scherrer A.U., Hasse B., von Wyl V., Yerly S., Böni J., Bürgisser P., Klimkait T., Bucher H.C., Ledergerber B. and Günthard H.F.
    Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS).
HIV Med. 2009, 10:647-656.
34: Schmutz S., Bosco N., Chappaz S., Boyman O., Acha-Orbea H., Ceredig R., Rolink A.G. and Finke D.
    Cutting edge: IL-7 regulates the peripheral pool of adult ROR gamma+ lymphoid tissue inducer cells.
J. Immunol. 2009, 183:2217-2221.
35: Simioni S., Ruffieux C., Kleeberg J., Bruggimann L., du Pasquier R.A., Annoni J.M. and Schluep M.
    Progressive decline of decision-making performances during multiple sclerosis.
J. Int. Neuropsychol. Soc. 2009, 15:291-295.
36: Spertini F. and Seebach J.
    Allergology and clinical immunology: a crossover discipline.
Rev. Med. Suisse 2009, 5:803-804.
37: Spertini F., Berney M., Foradini F. and Roulet C.A.
    Major mite allergen Der f 1 concentration is reduced in buildings with improved energy performance.
Allergy 2009. In press.
38: Taegtmeyer A.B., Steurer-Stey C., Price D.B., Wildhaber J.H., Spertini F. and Leuppi JD.
    Predictors of asthma control in everyday clinical practice in Switzerland.
Curr. Med. Res. Opin. 2009, 25:2549-2555.
39: Taegtmeyer A.B., Steurer-Stey C., Spertini F., Bircher A., Helbling A., Miedinger D., Schafroth S., Scherer K. and Leuppi J.D.
    Allergic rhinitis in patients with asthma: the Swiss LARA (Link Allergic Rhinitis in Asthma) survey.
Curr. Med. Res. Opin. 2009, 25:1073-1080.
40: Thierry A.C., Bernasconi E., Mercenier A. and Corthésy B.
    Conditioned polarized Caco-2 cell monolayers allow to discriminate for the ability of gut-derived microorganisms to modulate permeability and antigen-induced basophil degranulation.
Clin. Exp. Allergy 2009, 39:527-536.
41: Webster K.E., Walters S., Kohler R.E., Mrkvan T., Boyman O., Surh C.D., Grey S.T. and Sprent J.
    In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression.
J. Exp. Med. 2009, 206:751-760.
42: Wild J., Bieler K., Köstler J., Frachette M.J., Jeffs S., Vieira S., Esteban M., Liljeström P., Pantaleo G., Wolf H. and Wagner R.
    Preclinical evaluation of the immunogenicity of C-type HIV-1-based DNA and NYVAC vaccines in the Balb/C mouse model.
Viral Immunol. 2009, 22:309-319.

Publications : 2008 Debut de page
1: Aubert V., Graf Pisler I. and Spertini F.
    Improved diagnoses of autoimmune hepatitis using an anti-actin ELISA.
J. Clin. Lab. Anal. 2008, 22:340-345.
2: Bandelier C., Leimgruber A., Wassenberg J., Bart P.-A. and Spertini F.
    Rare food allergies.
Rev. Med. Suisse 2008, 4:1024-1026, 1028-1029.
3: Bart P.-A., Goodall R., Barber T., Harari A., Guimaraes-Walker A., Khonkarly M., Sheppard N.C., Bangala Y., Frachette M.J., Wagner R., Liljeström P., Kraehenbuhl J.-P., Girard M., Goudsmit J., Esteban M., Heeney J., Sattentau Q., McCormack S., Babiker A., Pantaleo G. and Weber J.; EuroVacc Consortium.
    EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium.
Vaccine 2008, 26:3153-3161.
4: Bart P.-A.
    When should consider antiphospholipid syndrome ?
Rev. Med. Suisse 2008, 4:97-99.
5: Berguiga M., Abouzeid H., Bart P.-A. and Guex-Crosier Y.
    Severe occlusive vasculitis as a complication of cat scratch disease1.
Klin. Monatsbl. Augenheilkd. 2008, 225:486-487.
6: Betts M.R. and Harari A.
    Phenotype and function of protective T cell immune rsponses in HIV.
Curr. Opin. HIV AIDS 2008, 3:349-355.
7: Boyman O., Ramsey C., Kim D.M., Sprent J. and Surh C.D.
    IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia.
J. Immunol. 2008, 180:7265-7275.
8: Brembilla N.C., Weber J., Rimoldi D., Pradervand S., Schutz F., Pantaleo G., Ruegg C., Quadroni M., Harshman K. and Doucey M.-A.
    c-Cbl expression levels regulate the functional responses of human central and effector memory CD4 T cells.
Blood 2008, 112:652-660.
9: Burkhard P.R., Vingerhoets F.J., Landis T. and Du Pasquier R.A.
    Neuropsychiatry.
Rev. Med. Suisse 2008, 4:1131-1132.
10: Burton C.T., Goodall R.L., Samri A., Autran B., Kelleher A.D., Poli G., Pantaleo G., Gotch F.M., Imami N.; INITIO Trial International Co-ordinating Committee.
    Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy.
Clin. Exp. Immunol. 2008, 152:252-257.
11: Castro E., Bélair M., Rizzardi G.P., Bart P.-A., Pantaleo G. and Graziosi C.
    Independent evolution of hypervariable regions of HIV-1 gp120: V4 as a swarm of N-Linked glycosylation variants.
AIDS Res. Hum. Retroviruses 2008, 24:106 -113.
12: Cereda C. and Du Pasquier R.
    Neurology.
Rev. Med. Suisse 2008, 9;4:49-50, 52-56.
13: Ciuffreda D., Comte D., Cavassini M., Giostra E., Bühler L., Perruchoud M., Heim M.H., Battegay M., Genné D., Mulhaupt B., Malinverni R., Oneta C., Bernasconi E., Monnat M., Cerny A., Chuard C., Borovicka J., Mentha G., Pascual M., Gonvers J.J., Pantaleo G. and Dutoit V.
    Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.
Eur. J. Immunol. 2008, 38:2665-2677.
14: Corbett M., Bogers W.M., Heeney J.L., Gerber S., Genin C., Didierlaurent A., Oostermeijer H., Dubbes R., Braskamp G., Lerondel S., Gomez C.E., Esteban M., Wagner R., Kondova I., Mooij P., Balla-Jhagjhoorsingh S., Beenhakker N., Koopman G., van der Burg S., Kraehenbuhl J.-P. and Le Pape A.
    Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic.
Proc. Natl. Acad. Sci. USA 2008, 105:2046-2051.
15: Ehrhard S., Wernli M., Kaufmann G., Pantaleo G., Rizzardi G.P., Gudat F., Erb P. and Battegay M.
    Effect of antiretroviral therapy on apoptosis markers and morphology in peripheral lymph nodes of HIV-infected Individuals.
Infection 2008, 36:120-129.
16: Gaucher D., Therrien R., Kettaf N., Angermann B.R., Boucher G., Filali-Mouhim A., Moser J.M., Mehta R.S., Drake III D.R., Castro E., Akondy R., Rinfret A., Yassine-Diab B., Said E.A., Chouikh Y., Cameron M.J., Clum R., Kelvin D., Somogyi R., Greller L.D., Balderas R.S., Wilkinson P., Pantaleo G., Tartaglia J., Haddad E.K. and Sékaly R.-P.
    Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses.
J. Exp. Med. 2008, 205:3119-3131.
17: Harari A. and Pantaleo G.
    HIV-1-specific immune response.
Adv. Pharmacol. 2008, 56:75-92.
18: Harari A., Bart P.-A., Stöhr W., Tapia G., Garcia M., Medjitna-Rais E., Burnet S., Cellerai C., Erlwein O., Barber T., Moog C., Liljestrom P., Wagner R., Wolf H., Kraehenbuhl J.-P., Esteban M., Heeney J., Frachette M.J., Tartaglia J., McCormack S., Babiker A., Weber J. and Pantaleo G.
    An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.
J. Exp. Med. 2008, 205:63-77.
19: Harari A., Bellutti Enders F., Garcia M. and Pantaleo G.
    Insight in the factors associated with the presence of protective antiviral T-cell response.
Cytometry B. Clin. Cytom. 2008, 1:47.
20: Jilek S., Schluep M., Meylan P., Vingerhoets F., Guignard L., Monney A., Kleeberg J., Le Goff G., Pantaleo G. and Du Pasquier R.A.
    Strong EBV-specific CD8+ T cell response in patients with early multiple sclerosis.
Brain 2008, 131:1712-1721.
21: Kleeberg J., Maire R., Chave J.-P., Pournaras J.-A., Guex-Crosier Y. and Du Pasquier R.A.
    Inaugural description of Cogan syndrome in an HIV-infected person.
J. Neurol. 2008, 255:1427-1428.
22: Leimgruber A.
    Allergic reactions to nonsteroidal anti-inflammatory drugs.
Rev. Med. Suisse 2008, 4:100-103.
23: McCormack S., Stöhr W., Barber T., Bart P.-A., Harari A., Moog C., Ciuffreda D., Cellerai C., Cowen M., Gamboni R., Burnet S., Legg K., Brodnicki E., Wolf H., Wagner R., Heeney J., Frachette M.J., Tartaglia J., Babiker A., Pantaleo G. and Weber J.
    EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone.
Vaccine 2008, 26:3162-3174.
24: Miconnet I. and Pantaleo G.
    A soluble hexameric form of CD40 ligand activates human dendritic cells and augments memory T cell response.
Vaccine 2008, 26:4006-4014.
25: Muhlbacher A., Weber B., Burgisser P., Eiras A., Cabrera J., Louisirirotchanakul S., Tiller F.W., Kim H.S., Helden J.V., Bossi V. and Echevarria J.M.
    Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants.
Med. Microbiol. Immunol. 2008, 197:55-64.
26: Pantaleo G.
    HIV-1 T-cell vaccines: evaluating the next step.
Lancet Infect. Dis. 2008, 8:82-83.
27: Perreau M., Pantaleo G. and Kremer E.J.
    Activation of a dendritic cell–T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells.
J. Exp. Med. 2008, 205:2717-2725.
28: Petitpierre S., Bart P.-A., Spertini F. and Leimgruber A.
    The multiple etiologies of angioedema
Rev. Med. Suisse 2008, 4:1030-1034, 1036-1038.
29: Petropoulos I.K., Zuber J.-P. and Guex-Crosier Y.
    Heerfordt syndrome with unilateral facial nerve palsy: a rare presentation of sarcoidosis.
Klin. Monatsbl. Augenheilkd. 2008, 225:453-456.
30: Sprent J., Cho J.H., Boyman O. and Surh C.D.
    T cell homeostasis.
Immunol. Cell. Biol. 2008, 86:312-319.
31: Thierrin L., Steiger D., Zuber J.-P., Spertini F., Brunisholz Y. and Delaloye J.-F.
    Severe anaphylactic shock to Patent Blue V with cardiac arrest during breast carcinoma surgery with lymphatic mapping.
Eur. J. Obstet. Gynecol. Reprod. Biol. 2008, 140:140-141.
32: Villard J. and Spertini F.
    The eternal gap...
Rev. Med. Suisse 2008, 4:1011.
33: Weiser B., Philpott S., Klimkait T., Burger H., Kitchen C., Bürgisser P., Gorgievski M., Perrin L., Piffaretti J.C. and Ledergerber B.; Swiss HIV Cohort Study.
    HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy.
AIDS 2008, 22:469-479.
34: Zuber J.-P., Bart P.-A., Leimgruber A. and Spertini F.
    Behçet's disease: from hippocrates to TNF-alpha-blockers.


Dernière modification le 25.05.2010 - Impressum - Informations juridiques

Home
Organisation Clinique Diagnostic Formation